BioArctic AB
Developing innovative drugs for neurodegenerative CNS disorders through advanced research.
Yleiskatsaus
- 100–199
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2000
- Perustettu
Avainpäättäjät
Oskar Bosson
VP, Head of IR & Communication
Lars Lannfelt
Board member
Anna-Lena Engwall
Board member
Mikael Moge
VP, Head of CMC
+16 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioArctic is a Swedish research-oriented biopharma company dedicated to revolutionizing treatments for neurodegenerative disorders. The organization focuses intensely on developing disease-modifying drugs for conditions such as Alzheimer’s disease, Parkinson’s disease, and ALS. They leverage 20 year...